Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Roche divulges new seprase-specific antibodies

March 12, 2012

New PARP-1 inhibitors with anticancer potential developed in China

March 12, 2012

Apogenix's phase II trial in glioblastoma multiforme meets primary endpoint

March 9, 2012

Study of AEZS-130 in cancer cachexia begins

March 9, 2012

Apexigen grants license for APX-004 development in China

March 9, 2012

Isis launches phase I trial of first-generation antisense drug

March 9, 2012

Novel kinase inhibitors patented

March 8, 2012

Eisai receives complete response letter on Dacogen

March 7, 2012

Novel kinase inhibitors developed in Spain

March 7, 2012

International phase III trial of MLN-8237 begins

March 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...